4. Medical Emergencies: Cardiovascular Flashcards

1
Q

Atherosclerosis “ a chronic ____

response in the walls of arteries caused by the formation of multiple ____ ”

A

inflammatory

plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical Manifestations of Atherosclerosis

NONCARDIAC

Diabetes mellitus
-diabetic ____ and
blindness
-increased ____ rate -poor healing of ____ limbs

Cerebral arteries

  • ____ attack
  • cerebrovascular ____
A

retinopathy
infection
lower

transient ischemic
infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical Manifestations of Atherosclerosis

CARDIAC

Coronary artery disease

  • ____ pectoris
  • ____ angina
  • ____ infarction
  • ____ failure
  • ____
  • ____ death (cardiopulmonary arrest)
A

angina
unstable

myocardial
congestive heart

dysthrythmias

sudden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Coronary Artery Disease “ the end result of the

accumulation of plaques ____ the walls of the arteries that supply the myocardium with oxygen and nutrients ”

A

within

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Again, coronary artery disease can manifest as ____ pectoris, or chest pain as we know it. This can be of a ____ variety which occurs only with exertion. So some kind of stressful event like after walking a couple blocks. This can be ____ when it happens at rest. Or if its happening at an increasing frequency – if the patient is having daily episodes of chest pain this would be unstable angina.

There’s also a variant called ____ disease and that’s also a form of angina, which will not be plaque formation in the coronary vessels but will result from ____ of the coronary vessels. So the lumen of those vessels will be diminished. We need those vessels to supply oxygen and nutrients to the heart so patients will manifest with the same kind of symptoms – chest pain – when they have this issue as well. And coronary artery disease can obviously lead to ____ and cardiopulmonary ____.

A

angina
stable
unstable

prinzmetal
spasm
MI
arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Coronary Artery Disease: Incidence and Prevalence
● Affects approximately 14 million people
in the United States
● ____ cause of death
● Approximately 500,000-700,000 deaths
are caused by coronary artery disease annually in the United States

A

leading

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If you look at the various age groups – you look at these younger age groups (the 5-14, 15-24, 25-44 age groups) the most common cause of deaths in these patients are ____ deaths as well as ____ being the second most common in the younger age groups (5-14, 15-24).

We do start to see ____ disease creep up in the 25-44 age groups (as the second most common cause of death), more so in the patients over ____ or late 30’s that we see heart disease surpass cancer as the ____ most common cause of death.

A

accidental
cancer

heart
40
second

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Then we will see in the 45-64 year old group and the older elderly individuals, the 85+, that ____ disease predominates as the ____ killer in these two groups, followed by cancer, and then you see ____ accidents or strokes. So these problems are prevalent. Atherosclerosis manifesting in the brain in the form of CVA and in the heart in the form of coronary heart disease.

A

heart
leading
cerebrovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Coronary Artery Disease: Risk Factors

Uncontrollable:
● ____
● ____
● ____ history

Controllable:
● Hypertension 
● Smoking 
● Hypercholesterolemia 
● Diabetes 
● Obesity 
● Stress 
● Type A personality 
● Sedentary lifestyle
A

male
age
family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sex
● ____ have a greater incidence of
CAD than females
● Women follow men by ____ years

A

males

10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Age
● Increasing ____ = increasing CAD
● ____ risk factor
● ____ persons experience higher mortality and morbidity rates from CAD

A

age
strongest
elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypertension

“ a consistent state of elevated blood pressure above ____ mm Hg ”

A

140/90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Classification of Blood Pressure

HTN: Stage 3
Systolic (mmHg): \_\_\_\_
HTN: Stage 2
Systolic (mmHg): \_\_\_\_
HTN: Stage 1
Systolic (mmHg): \_\_\_\_

Borderline HTN: Systolic (mmHg): ____

Normal: Systolic (mmHg): ____

A

> 180
160-179
=140-159

135-139

<135

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Classification of Blood Pressure

HTN: Stage 3
Diastolic (mmHg): \_\_\_\_
HTN: Stage 2
Diastolic (mmHg): \_\_\_\_
HTN: Stage 1
Diastolic (mmHg): \_\_\_\_

Borderline HTN: Systolic (mmHg): ____

Normal: Systolic (mmHg): ____

A

> 110
100-109
90-99

85-89

85

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypertension: Etiology
● Essential (idiopathic) - accounts for
____%; obesity, salt sensitivity, renin homeostasis, insulin resistance, genetics, and age may be contributing factors

● Secondary - result of identifiable process
such as ____, primary aldosteronism, ____ syndrome, oral contraceptives, or renal disease

A

90-95
pheochromocytoma
cushing’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hypertension: Incidence

● ____% of U.S. population has hypertension

A

20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hypertension: Clinical Presentation

1st stage:
no ____

2nd stage:
\_\_\_\_ (occipital) 
\_\_\_\_ 
\_\_\_\_ 
\_\_\_\_ 
\_\_\_\_ changes – arteriolar narrowing
\_\_\_\_ changes
3rd stage:
\_\_\_\_, MI 
Accelerated \_\_\_\_ 
CHF, \_\_\_\_ 
Blindness 
Proteinuria, \_\_\_\_ 
CVA
A

symptoms

headaches
vertigo
flushing
epistaxis
retinal
EKG

angina
atherosclerosis
LVH
ESRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Modified Stepped- Care Approach to Hypertension

Step 1. Begin with medically-supervised ____ changes and observation

Step 2. Begin pharmacologic therapy with one
of the following:
- a \_\_\_\_
- an  \_\_\_\_ blocker
- an \_\_\_\_ inhibitor
- an \_\_\_\_ antagonist
- a \_\_\_\_ channel blocker

Step 3. Continue ____ drugs of different pharmacologic class found in step 2.

A

lifestyle

diuretic
a or b
ACE
angiotensin II receptor
calcium

two

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dental Management of the Hypertensive Patient: Reduction of Stress and Anxiety
● Establish honest, supportive relationship with
patient
● Discuss patient’s questions, concerns, fears
● Schedule ____ appointments
● Avoid ____ appointments
● Use pre-medication as needed - ____
● Use ____ as needed (avoid hypoxia)
● Provide gradual changes of position to avoid ____
● Avoid stimulating ____ reflex
● ____ patient if he or she appears to be overstressed

A
morning
long
diazepam
nitrous oxide
postural hypotension
gag
dismiss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Smoking

● In males, 5 fold greater risk of ____ and a 3 fold greater risk of fatal ____ when compared to non-smokers

A

CVA

MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cholesterol
● Typical daily internal production is about ____ g and dietary intake is ____ mg
● Primarily synthesized from ____ through the HMG-CoA reductase pathway
● ____ in blood
● Transported in the circulatory system within lipoproteins
● Higher concentrations of ____ and lower concentrations of ____ are strongly associated with cardiovascular disease because these promote atherosclerosis

A
1
200-300
acetyl CoA
insoluble
LDL
HDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cholesterol: Guidelines
● < ____ mg/dl = normal
● ____ mg/dl = borderline
● > ____ mg/dl = high risk; ____ X increase in
heart disease
● > ____ mg/dl = ____ X increase in heart disease

A
200
200-239
240
2
300
4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cholesterol: Guidelines
Total Cholesterol < ____ mg/dl
HDL >____ mg/dl
LDL

A

200
70
100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Lipid-Lowering Drugs
Bile Acid Sequestrants
____
Colestipol

HMG CoA Reductase Inhibitors 
Atorva\_\_\_\_
Fluvastatin 
Lovastatin 
Simvastatin 
Pravastatin

Fibric Acid Derivatives
____

Miscellaneous drugs and natural compounds 
\_\_\_\_ 
\_\_\_\_ 
\_\_\_\_ (vitamin B3, niacin) 
\_\_\_\_
A
cholestyramine
statin
gemfibrozil
estrogens
probucol
nicotinic acid
vitamin E
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Diabetes

● ____ X risk for CAD when ____ is present

A

2

diabetes mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q
Obesity
Increased risk of:
\_\_\_\_ disease 
Hypertension
 \_\_\_\_ 
Type II diabetes mellitus 
\_\_\_\_ 
Obstructive sleep apnea
A

coronary artery
hypercholesterolemia
osteoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Alcohol
● “Moderate” consumption
increases serum levels of
____

A

HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q
Laboratory Tests for Coronary Heart Disease
● \_\_\_\_ blood tests 
● \_\_\_\_ lipid profile 
● Twelve-lead \_\_\_\_ 
● \_\_\_\_ ECG stress test 
● \_\_\_\_ 
● \_\_\_\_ imaging studies using thallium, sestamibi, or teboroxime 
● \_\_\_\_, adenosine or dobutamine nuclear
stress test 
● \_\_\_\_ angiography 
● Increased \_\_\_\_ markers
A
routine
fasting
ECG
treadmill
echocardiography
nuclear
persantine
MR
serum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Management of CAD
● ____% reduction in mortality from CAD over the past 3 decades

● Prevention
◆ Control ____ factors
◆ ____ modification
◆ ____

● Treatment
◆ Medical
◆ Surgical

A

30
risk
lifestyle
aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

CAD: Treatment

● Medical therapy:
◆ Drugs
◆ Alter risk factors
◆ ____ (PTCA)

A

percutaneous transluminal coronary angioplasty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q
Drugs Used in the Treatment of Coronary Artery Disease
● \_\_\_\_ 
● \_\_\_\_ 
● \_\_\_\_-blockers 
● \_\_\_\_ channel blockers 
● \_\_\_\_ inhibitors 
● \_\_\_\_
A
nitroglycerin
aspirin
B
calcium
ACE
statins
32
Q

Protective Effects of Aspirin Against Acute Myocardial Infarction and Death in Men with Unstable Angina: Results of a Veterans Administration Study

Aspirin has a ____ effect against acute ____ in men with unstable angina and a similar effect on mortality
● Double Blind: 1266 men (625 aspirin/641 placebo) ● 324 mg of aspirin in a buffered solution
● 12 week duration
● MI and death 51% lower in aspirin group

A

protective

myocardial infarction

33
Q

Percutaneous Transluminal Coronary Angioplasty (PTCA)

PTCA. Again this is more considered ____ management. It isn’t actual surgery but basically a catheter is placed in the patient’s groin in the ____ artery and the catheter with wire is gone all the way to the coronary vessels, and you can see a blockage in the left main vessel by the arrow there. And what percutaneous transluminal coronary angioplasty is basically a ____ that is inserted into that vessel and that balloon is inflated, then you can see the reperfusion after that procedure has been done in the angiogram to the right.

This is an angiogram you can see the vasculature of the entire heart with this and we can see if there’s any blockages. So if a patient comes into the hospital with chest pain they may perform this this is exactly where the clot is and they can bypass that and get flow of blood that you can see there.

A

medical
femoral
balloon

34
Q

Percutaneous Transluminal Coronary Angioplasty (PTCA)
● 30-40% ____ after
conventional angioplasty
● Currently 70-90% of patients have ____ inserted simultaneously

A

re-stenosis

stents

35
Q

CAD: Treatment
● Surgical therapy:
◆ ____

A

coronary artery bypass grafts

36
Q

Coronary Artery Bypass Graft (CABG)
● 600,000 a year in the U.S.
● ____, internal mammary artery, and radial artery

● Recommended for:
◆ Disease of the \_\_\_\_ coronary artery 
◆ Disease of \_\_\_\_ or more vessels 
◆ Cases in which non-surgical management
hasn't \_\_\_\_
A

saphenous vein

left main
three
worked

37
Q

CABG
●  Mortality rate of 1% - 2%
●  ____ incidence at 0.4% - 13%
●  Risk of ____ damage (e.g. memory loss,
confusion, dementia)
●  Saphenous vein does only about ____% of the work

A

stroke
brain
10

38
Q

The relation of risk factors to the development of atherosclerosis in … bypass grafts:
10 Year Study
●  132 grafts
◆  1st year all patent
◆  10 years 50% patent
●  Atherosclerosis is a progressive disease
affecting grafts and native vessels
●  Progression may be related to elevated to
elevated levels of plasma ____ (VLDL, LDL)

A

lipoprotein

39
Q

Angina Pectoris
a complex of symptoms
highlighted by transient chest
pain due to ____

A

ischemia

40
Q
Angina Pectoris
Etiology:
 ●  Coronary \_\_\_\_  
●  Coronary embolus  
●  Coronary artery spasm  
●  Coronary arteritis  
●  Reduction in \_\_\_\_ 
 ●  Reduction in \_\_\_\_

● Aortic ____
● Aortic insufficiency

A

atherosclerosis
BP
CO

stenosis

41
Q

Angina Pectoris

Chest Pain Characteristics:
____ intensity
____ localized retrosternal pain
Radiation of the pain to the ____ arm and
shoulder or neck and mandible
____ duration (2-10 minutes) relieved by ____ (noticeably within 2 minutes)

A
moderate
poorly
left
brief
nitroglycerin
42
Q
Angina Pectoris
 Associated symptoms:
     ●  \_\_\_\_      
●  \_\_\_\_      
●  weakness     
 ●  \_\_\_\_
        ●  diaphoresis
     ●  increase in heart rate and \_\_\_\_
A

nausea
salivation
pallor
BP

43
Q
Angina Pectoris
Diagnosis:
 1. \_\_\_\_  
2. \_\_\_\_
 ●   Rest  
●   Exercise –stress
 3. \_\_\_\_
A

history
EKG
coronary angiography

44
Q

Medical Management of the Patient with Angina Pectoris
●  Explanation and reassurance
●  Reduction of risk factors

●  Drug therapy
 \_\_\_\_     
\_\_\_\_
\_\_\_\_ Blockers
 \_\_\_\_-channel blockers
  \_\_\_\_
●  Percutaneous transluminal coronary
angioplasty (PTCA) 
●  Coronary artery bypass grafting (CABG)
A
nitrates
aspirin
B
calcium
statins
45
Q
Differential Diagnosis of  Chest Pain
   \_\_\_\_ disease    
Angina    
Myocardial infarction    
\_\_\_\_ hernia    
\_\_\_\_    
\_\_\_\_ disease
A

musculoskeletal
hiatil
gastritis
gallbladder

46
Q

Angina Pectoris
Stable Angina
Pain on ____, relief with ____

Unstable Angina
Pain at Up to 1/month or markedly changing ____ of attacks

A

exertion
rest

rest
frequency

47
Q

Mild Angina

Frequency of attack
Up to ____/month

Stability
____

Changing frequency
____

Onset
Following severse ____ or emotion

Medications
____ (symptomatically)

A
1
stable
none
exercise
nitroglycerin
48
Q

Moderate Angina

Frequency of attack
Up to ____/wk

Stability
____

Changing frequency
Slight ____ over
previous year or more
distant past

Onset
Following ____ or
emotion or (infrequently) meals

Medications
\_\_\_\_; long
acting nitrates; \_\_\_\_
blockers; calcium
channel blockers
A
1
stable
increase
exertion
nitroglycerin
B
49
Q

Severe Angina

Frequency of attack
____ episodes

Stability
____

Changing frequency
Changes in last ____ months

Onset
Following ____, decreasing or mild emotion or exertion, and meals (frequently)

Medications
\_\_\_\_; long
acting nitrates; \_\_\_\_
blockers; calcium
channel blockers
A
daily
unstable
6
rest
nitroglycerin
beta
50
Q

Treatment of angina in the dental office

  1. ____ dental treatment
  2. Recline patient to ____ degree angle; lower head
    position if systolic BP
A

stop
45
100

nitroglycerin
3-5
5
therapeutic
MI
51
Q

reatment of angina in the dental office (cont.)

  1. ____ administration
  2. If pain persists after the above therapy
    a. Transport the patient to hospital by ambulance
    b. Monitor blood pressure and pulse every ____ min.
    c. Be prepared to administer cardiopulmonary resuscitation in the event of an arrest
A

O2

5

52
Q

Myocardial Infarction
irreversible damage to the myocardium due to prolonged
____ injury

A

ischemic

53
Q

Myocardial Infarction: Clinical Presentation
● Severe chest pain is present in ____ or left precordial area, +/- left arm, ____ radiation
● Dyspnea, fatigue, palpitations, nausea, and vomiting

A

substernal

jaw

54
Q

Myocardial Infarction: Etiology
● Most commonly the result of
progressive coronary artery disease secondary to ____

A

atherosclerosis

55
Q

Myocardial Infarction: Diagnosis
● ____ presentation
● ____
● Cardiac ____ studies

A

clinical
electrocardiogram
enzyme

56
Q
Myocardial Infarction: First -line treatment
●  \_\_\_\_ 
●  \_\_\_\_ 
●  \_\_\_\_ 
●  \_\_\_\_
A

morphine
oxygen
nitroglycerin
aspirin

57
Q

Myocardial Infarction: Secondary Treatment
●  ____-blockers
●  ____ agents

●  Reperfusion therapy
◆  ____ therapy
◆  PTCA
◆  CABG

A

B
anticoagulant
thrombolytic

58
Q

Myocardial Infarction: Prognosis
●  Associated with a 30% mortality rate; half of the deaths occur ____
to arrival at the hospital
●  An additional 5-10% of survivors die within the ____ year after their MI
●  Risk of mortality and morbidity is 1.5-15 X greater than that of the rest of the population

A

prior

first

59
Q

Myocardial Infarction: Complications
●  Extension of infarction or ____
●  ____
●  ____failure

A

reinfarction
arrhythmias
congestive heart

60
Q


If they need emergency surgery, will be done in hospital setting
We do not treat these patients in the post-M.I. period - ____ months
Especially if it’s only elective treatment

A

6

61
Q

Risk stays the same after 12 months, they are at ____ risk for the rest of their lives

A

greater

62
Q

Dental management of Patient with a history of myocardial infarction

  • consult ____ concerning management
  • no routine dental care until at least ____ mo post-infarct
  • patients on anticoagulation therapy needing deep scaling or surgical procedures
  • CHECK ____
  • have emergency equipment and drugs available
A

physician
6
INR

63
Q

●  With local anesthesia with 1:100,000 epinephrine; aspirate, inject slowly, and use no more than ____ cartridges
●  Avoid use of ____ to control local bleeding or in gingival packing material
●  If patient becomes fatigued or develops significant changes in heart rate or rhythm during appointment, ____ appointment at
that time

A

three
vasopressors
terminate

64
Q

Cardiac Arrest

Cause: Sudden circulatory and respiratory collapse. May be secondary to M.I., anaphylaxis, etc.

Signs and Symptoms

  1. Pulse – absent (use ____)
  2. B.P. – ____
  3. Resp. – ____ or agonal
  4. Skin - ____ - ashen grey
  5. Pupils - ____ and fixed
A
carotids
unobtainable
apnea
cyanotic
dilated
65
Q

Congestive Heart Failure

the inability of the heart to deliver an adequate supply of ____ to meet metabolic demands

A

blood

66
Q

Precipitating Factors in Congestive Heart Failure

●  \_\_\_\_ 
●  Myocardial infarction 
●  \_\_\_\_ and other
forms of myocarditis 
●  Arrhythmias 
●  Infective endocarditis
●  \_\_\_\_ 
●  Thyrotoxicosis 
●  \_\_\_\_ infection 
●  \_\_\_\_ embolism 
●  \_\_\_\_ 
●  Physical or emotional
\_\_\_\_
A

HTN
rheumatic

anemia
pulmonary
pulmonary
pregnancy
stress
67
Q

Symptoms of Congestive Heart Failure

Left-sided heart failure (____): Fatigue
____ (shortness of breath), especially on exertion ____
____ dyspnea

Right-sided heart failure (PORTAL):
____ of the ankles and legs
____
____ Pain

A

pulmonary
dyspnea
orthopnea
paroxysmal nocturnal

swelling
nausea
abdominal

68
Q

Signs of Congestive Heart Failure
Left-sided heart failure:
____

Right-sided heart failure:
 Distended \_\_\_\_ veins
 Large tender \_\_\_\_
 \_\_\_\_
\_\_\_\_
 \_\_\_\_ gain, increase body girth
A

pulmonary edema

neck
liver
ascites
peripehral edema
weight
69
Q

Management of the patient with congestive heart failure:
● ____ rest
● ____ modification
● Address potentially reversible factors
● Medications

A

bed

lifestyle

70
Q

Chair Position Guidelines
●  The dental chair should be placed in a semi- reclined or upright position (____ degrees)
●  At the end of the appointment, the chair should
be ____ raised to prevent orthostatic
hypotension

A

45

slowly

71
Q

Patient at low risk
● History of ____ congestive heart failure
● ____ on therapy
● Usually on mild diuretics, with or without
____

A

mild
asymptomatic
cardiac glycosides

72
Q

Patient at moderate risk
● History of ____ congestive heart failure
● Asymptomatic at rest, but may have symptoms with ____
● Usually on more ____ diuretics and ____

A

moderate
exertion
potent
cardiac glycosides

73
Q

Patient at high risk
● ____ despite therapy
● Often on ____ doses of medications, including vasodilators
● Has significant ____ dysfunction

A

symptomatic
escalating
cardiac

74
Q

Cardiac Arrhythmias

Isolated ectopic beats
●  ____ atrial beats
●  Premature ventricular beats

Bradycardias
●  Sinus ____
●  Heart block

Tachycardias
●   Sinus \_\_\_\_ 
●    Atrial flutter 
●    Atrial fibrillation 
●    Ventricular tachycardia 
●    Ventricular fibrillation
A

premature
bradycardia
tachycardia

75
Q

Signs and Symptoms of Cardiac Arrhythmias

Signs
●  Slow heart rate (less than
\_\_\_\_ beats per minute) 
●  Fast heart rate (greater
than \_\_\_\_ beats per
minute) 
●  Irregular heart rate 
●  \_\_\_\_ 
●  Congestive heart failure 
●  Cardiac arrest
Symptoms
●  Palpitations 
●  Fatigue 
●  Dizziness 
●  Angina
A

60
100
syncope

76
Q

Dental Management of the Patient at Risk for Cardiac Arrhythmia
● Reduce ____
● Avoid excessive amounts of epinephrine (

A

anxiety
3
cardiac anesthesia